NEW YORK – The U.S. Food and Drug Administration is investigating whether the popular heartburn drug Zantac causes carcinogens to form in the bodies of users, in an effort to fully understand the risks posed by the already recalled drug, the agency’s spokesman said on Thursday. The issue of whether ranitidine, commonly known as Zantac, causes levels of the probable carcinogen N-nitrosodimethylamine (NDMA) to rise in users’ bodies has been raised previously by Valisure, an online pharmacy that originally flagged the potential contamination of ranitidine to the FDA. Zantac, sold over-the-counter in the United States by French drugmaker Sanofi SA, and [...]
About maxdm이 저자는 아직 상세 내용을 기재하지 않았습니다.
So far maxdm has created 13 blog entries.
maxdm2020-01-07T15:24:16+09:00FDA investigating heartburn drug Zantac for carcinogen risksmaxdm2020-01-07T15:24:16+09:00